|
Volumn 18, Issue 5, 2012, Pages 245-247
|
IPSCs from cancer cells: Challenges and opportunities
|
Author keywords
Cancer cells; Induced pluripotent stem cells; Oncogenesis; Reprogramming; Transformation
|
Indexed keywords
CYCLIN DEPENDENT KINASE INHIBITOR 1;
CYCLIN DEPENDENT KINASE INHIBITOR 2A;
KRUPPEL LIKE FACTOR 4;
MICRORNA;
OCTAMER TRANSCRIPTION FACTOR 4;
PROTEIN P19;
PROTEIN P53;
TRANSCRIPTION FACTOR SOX2;
ATAXIA TELANGIECTASIA;
B LYMPHOCYTE;
CANCER CELL;
CANCER STEM CELL;
CELL IMMORTALIZATION;
CELL TRANSFORMATION;
CELL TRANSPLANTATION;
CELL TYPE;
CHROMOSOME TRANSLOCATION;
CHRONIC MYELOID LEUKEMIA;
DNA DAMAGE;
DNA METHYLATION;
DNA MODIFICATION;
DOUBLE STRANDED DNA BREAK;
DRUG SCREENING;
EPIGENETICS;
GENE EXPRESSION;
GENE SEQUENCE;
HUMAN;
LEUKEMIA CELL;
LYMPHOBLAST;
MELANOMA;
NUCLEAR REPROGRAMMING;
ONCOGENE C MYC;
ONTOGENY;
OOCYTE;
PLURIPOTENT STEM CELL;
PROGERIA;
SENESCENCE;
SHORT SURVEY;
WILD TYPE;
ANIMALS;
CELL DIFFERENTIATION;
HUMANS;
INDUCED PLURIPOTENT STEM CELLS;
NEOPLASMS;
NUCLEAR REPROGRAMMING;
TRANSCRIPTION FACTORS;
|
EID: 84860517655
PISSN: 14714914
EISSN: 1471499X
Source Type: Journal
DOI: 10.1016/j.molmed.2012.04.001 Document Type: Short Survey |
Times cited : (61)
|
References (10)
|